We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
47 hedge funds and large institutions have $302M invested in Jade Biosciences in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
15% more funds holding
Funds holding: 41 → 47 (+6)
0.46% more ownership
Funds ownership: 2.53% → 2.99% (+0.46%)
33% less capital invested
Capital invested by funds: $453M → $302M (-$151M)
Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.72%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
12
Increased
16
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$3.57M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$2.6M |
| 3 |
FAM
Fred Alger Management
New York
|
+$2.41M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.47M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$626K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$15M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.52M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.89M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.53M |
| 5 |
Millennium Management
New York
|
-$1.47M |
